2016
DOI: 10.4238/gmr.15017888
|View full text |Cite
|
Sign up to set email alerts
|

Iron translocation in Pleurotus ostreatus basidiocarps: production, bioavailability, and antioxidant activity

Abstract: ABSTRACT. Translocation of minerals from substrate to mushrooms can change the medicinal characteristics, commercial value, and biological efficiency of mushroom. In the present study, we demonstrated that addition of iron to the substrate reduces the yield of Pleurotus ostreatus mushroom. The biological efficiency of the mushroom varied from 36.53% on the unsupplemented substrate to 2.08% for the substrate with 500 mg/kg iron added. The maximum iron concentration obtained for mushroom was 478.66 mg/kg (dry ba… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
16
0
3

Year Published

2016
2016
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(20 citation statements)
references
References 22 publications
1
16
0
3
Order By: Relevance
“…Selenium‐enriched C. versicolor mycelium could be used as a potentially novel pharmaceutical, not just as a source of selenium, but also as a source of other micro and macroelements. Although the cultivation of mushrooms in liquid medium enriched with iron is possible, this process has some disadvantages, such as potential toxic effects of high iron concentrations and changes in mushroom flavor, which could reduce the acceptability of potential iron‐enriched mushrooms nutraceuticals [46]. Considering that the maximum tolerated daily intake of selenium in Europe is 300 μg [47], the use of selenium‐enriched C. versicolor mushroom biomass as a source of other microelements, statutory limits established for some elements are not exceeded, but the above‐mentioned values for RDA are not met.…”
Section: Discussionmentioning
confidence: 99%
“…Selenium‐enriched C. versicolor mycelium could be used as a potentially novel pharmaceutical, not just as a source of selenium, but also as a source of other micro and macroelements. Although the cultivation of mushrooms in liquid medium enriched with iron is possible, this process has some disadvantages, such as potential toxic effects of high iron concentrations and changes in mushroom flavor, which could reduce the acceptability of potential iron‐enriched mushrooms nutraceuticals [46]. Considering that the maximum tolerated daily intake of selenium in Europe is 300 μg [47], the use of selenium‐enriched C. versicolor mushroom biomass as a source of other microelements, statutory limits established for some elements are not exceeded, but the above‐mentioned values for RDA are not met.…”
Section: Discussionmentioning
confidence: 99%
“…Accordingly, previous studies have demonstrated that ethanolic extract from AA at 1 mg/mL showed an inhibitory activity against Sarcoma 180 cells (Reza et al, 2011;Reza et al, 2014). Mushrooms contain various compounds such as polysaccharides, proteins, fats, glycosides, phenols, flavonoids, carotenoids, organic acids, and minerals (Patel and Goyal, 2012;Yokota et al, 2016). Common active components in mushrooms such as polysaccharide, b-glucan, and protein-polysaccharide complex have been found to promote antitumor activities (Ooi and Liu, 2000).…”
Section: Discussionmentioning
confidence: 99%
“…The latter do not accumulate a large amount of metal ions that could elicit biological effects. The presence of iron decreases the antioxidant potential expressed in terms of iron chelation and radical scavenging [Yokota et al, 2016]. Use of mushroom mycelia can elicit rapid antioxidant effects due to a greater accessibility of bioactive compounds [Vamanu et al, 2013].…”
Section: Discussionmentioning
confidence: 99%